Immunotherapy of Equine Sarcoids-From: Early Approaches to Innovative Vaccines

Christoph Jindra; Edmund K Hainisch; Sabine Brandt

doi:10.3390/vaccines11040769

Immunotherapy of Equine Sarcoids-From: Early Approaches to Innovative Vaccines

Christoph Jindra, Edmund K Hainisch, Sabine Brandt

Karl Landsteiner University of Health Sciences

Research output: Journal article (peer-reviewed) › Review article

4 Citations (Scopus)

Abstract

Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.

Original language	English
Article number	769
Journal	Vaccines
Volume	11
Issue number	4
DOIs	https://doi.org/10.3390/vaccines11040769
Publication status	Published - Apr 2023

Access to Document

10.3390/vaccines11040769

Cite this

@article{4b984e2e0fee4aad8ba3362d52ff9038,

title = "Immunotherapy of Equine Sarcoids-From: Early Approaches to Innovative Vaccines",

abstract = "Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.",

author = "Christoph Jindra and Hainisch, {Edmund K} and Sabine Brandt",

note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = apr,

doi = "10.3390/vaccines11040769",

language = "English",

volume = "11",

journal = "Vaccines",

issn = "2076-393X",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "4",

}

TY - JOUR

T1 - Immunotherapy of Equine Sarcoids-From

T2 - Early Approaches to Innovative Vaccines

AU - Jindra, Christoph

AU - Hainisch, Edmund K

AU - Brandt, Sabine

PY - 2023/4

Y1 - 2023/4

N2 - Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.

AB - Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.

UR - http://www.scopus.com/inward/record.url?scp=85153785526&partnerID=8YFLogxK

U2 - 10.3390/vaccines11040769

DO - 10.3390/vaccines11040769

M3 - Review article

C2 - 37112681

SN - 2076-393X

VL - 11

JO - Vaccines

JF - Vaccines

IS - 4

M1 - 769

ER -

Immunotherapy of Equine Sarcoids-From: Early Approaches to Innovative Vaccines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this